NVIV
Tu y David la seguíais, no? Noticia un poco rara...
nVivo Therapeutics Expresses Condolences on Death of Eighth Patient Enrolled in INSPIRE Study
InVivo Therapeutics Holdings Corp. (NVIV) today announced that an eighth patient enrolled into The INSPIRE Study has died after injuries from a severe motor vehicle accident and unrelated to the investigational product.
http://finance.yahoo.com/news/invivo-therapeutics-expresses-condolences-death-120000046.html
DMPI, parecen buenos resultados de Fase I/II para VAL-083 em GBM, pero de momento, el valor no se mueve en absoluto..
Un saludo
http://finance.yahoo.com/news/delmar-pharmaceuticals-updates-ongoing-phase-131000807.html
GBM patients failing bevacizumab have a poor prognosis with expected survival under five months. To date, more than half of patients receiving an assumed therapeutic dose of VAL-083 (≥20mg/m2) have survived more than six months following bevacizumab failure; more than 40% have survived for nine months or are currently alive and more than 20% have survived for twelve months or are currently alive with median survival expected to be determined at between eight and nine months following bevacizumab failure.
gracias framus, me parece que hoy no llegamos a esos precios. Pongo el listón mas abajo ya que es solo para 1/4 de mis acciones.
ESPR
gracias, lo tendré en cuenta y voy a buscar más información.
Fuera SGYP a $3,75 (de la entrada de $2,89) Me dejo más de la mitad para largo
ILMN
Quien la ha visto y quien la ve... -22% por previsión a la baja de ingresos para Q1. Como está el patio!
Cambio orden venta NVAX 4K a 6 hasta fin de mes .....😉
No habia visto las SGYP como habian abierto, vaya, vaya ... los NDA ya no son lo que eran ...
